Product logins

Find logins to all Clarivate products below.


Biopsy Devices | Europe | 2016 | Market Analysis

The European market for biopsy devices will be primarily driven by wider implementation of national cancer screening programs, an increase in reimbursement coverage for biopsy procedures, increasing adoption of premium-priced devices, and favorable demographics; these factors will result in market growth through 2024.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for biopsy devices in Europe across a 10-year period.

Related Medtech Insights Reports

Report
Diagnostic Imaging Equipment Servicing – Market Insights – United States
The US diagnostic imaging equipment servicing market is projected to experience only marginal growth through 2034. Market expansion will be constrained largely by the rising adoption of advanced…
Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…